... >
organooxygen compound >
ester >
carboxylic ester >
lactone >
cyclodepsipeptide >
(2s)-n-[(2s,8s,11r,12s,15s,18s,21r)-2-benzyl-8-[(2r)-butan-2-yl]-21-hydroxy-5-[(4-hydroxyphenyl)methyl]-4,11-dimethyl-15-(2-methylpropyl)-3,6,9,13,16,22-hexaoxo-10-oxa-1,4,7,14,17-pentazabicyclo[16.3.1]docosan-12-yl]-5-(carbamoylamino)-2-(2-methylpropanoylamino)pentanamide
... >
organooxygen compound >
carbonyl compound >
carboxylic ester >
lactone >
cyclodepsipeptide >
(2s)-n-[(2s,8s,11r,12s,15s,18s,21r)-2-benzyl-8-[(2r)-butan-2-yl]-21-hydroxy-5-[(4-hydroxyphenyl)methyl]-4,11-dimethyl-15-(2-methylpropyl)-3,6,9,13,16,22-hexaoxo-10-oxa-1,4,7,14,17-pentazabicyclo[16.3.1]docosan-12-yl]-5-(carbamoylamino)-2-(2-methylpropanoylamino)pentanamide
organooxygen compound >
ester >
lactone >
cyclodepsipeptide >
(2s)-n-[(2s,8s,11r,12s,15s,18s,21r)-2-benzyl-8-[(2r)-butan-2-yl]-21-hydroxy-5-[(4-hydroxyphenyl)methyl]-4,11-dimethyl-15-(2-methylpropyl)-3,6,9,13,16,22-hexaoxo-10-oxa-1,4,7,14,17-pentazabicyclo[16.3.1]docosan-12-yl]-5-(carbamoylamino)-2-(2-methylpropanoylamino)pentanamide
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
pnictogen molecular entity >
nitrogen molecular entity >
organonitrogen compound >
carboxamide >
peptide >
depsipeptide >
cyclodepsipeptide >
(2s)-n-[(2s,8s,11r,12s,15s,18s,21r)-2-benzyl-8-[(2r)-butan-2-yl]-21-hydroxy-5-[(4-hydroxyphenyl)methyl]-4,11-dimethyl-15-(2-methylpropyl)-3,6,9,13,16,22-hexaoxo-10-oxa-1,4,7,14,17-pentazabicyclo[16.3.1]docosan-12-yl]-5-(carbamoylamino)-2-(2-methylpropanoylamino)pentanamide
... >
organooxygen compound >
carboxamide >
peptide >
depsipeptide >
cyclodepsipeptide >
(2s)-n-[(2s,8s,11r,12s,15s,18s,21r)-2-benzyl-8-[(2r)-butan-2-yl]-21-hydroxy-5-[(4-hydroxyphenyl)methyl]-4,11-dimethyl-15-(2-methylpropyl)-3,6,9,13,16,22-hexaoxo-10-oxa-1,4,7,14,17-pentazabicyclo[16.3.1]docosan-12-yl]-5-(carbamoylamino)-2-(2-methylpropanoylamino)pentanamide
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
pnictogen molecular entity >
nitrogen molecular entity >
amide >
primary amide >
carboxamide >
peptide >
depsipeptide >
cyclodepsipeptide >
(2s)-n-[(2s,8s,11r,12s,15s,18s,21r)-2-benzyl-8-[(2r)-butan-2-yl]-21-hydroxy-5-[(4-hydroxyphenyl)methyl]-4,11-dimethyl-15-(2-methylpropyl)-3,6,9,13,16,22-hexaoxo-10-oxa-1,4,7,14,17-pentazabicyclo[16.3.1]docosan-12-yl]-5-(carbamoylamino)-2-(2-methylpropanoylamino)pentanamide
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
carbon group molecular entity >
organic molecular entity >
organic amino compound >
peptide >
depsipeptide >
cyclodepsipeptide >
(2s)-n-[(2s,8s,11r,12s,15s,18s,21r)-2-benzyl-8-[(2r)-butan-2-yl]-21-hydroxy-5-[(4-hydroxyphenyl)methyl]-4,11-dimethyl-15-(2-methylpropyl)-3,6,9,13,16,22-hexaoxo-10-oxa-1,4,7,14,17-pentazabicyclo[16.3.1]docosan-12-yl]-5-(carbamoylamino)-2-(2-methylpropanoylamino)pentanamide
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
pnictogen molecular entity >
nitrogen molecular entity >
organonitrogen compound >
organic amino compound >
peptide >
depsipeptide >
cyclodepsipeptide >
(2s)-n-[(2s,8s,11r,12s,15s,18s,21r)-2-benzyl-8-[(2r)-butan-2-yl]-21-hydroxy-5-[(4-hydroxyphenyl)methyl]-4,11-dimethyl-15-(2-methylpropyl)-3,6,9,13,16,22-hexaoxo-10-oxa-1,4,7,14,17-pentazabicyclo[16.3.1]docosan-12-yl]-5-(carbamoylamino)-2-(2-methylpropanoylamino)pentanamide
اصطلاح مرجح
(2s)-n-[(2s,8s,11r,12s,15s,18s,21r)-2-benzyl-8-[(2r)-butan-2-yl]-21-hydroxy-5-[(4-hydroxyphenyl)methyl]-4,11-dimethyl-15-(2-methylpropyl)-3,6,9,13,16,22-hexaoxo-10-oxa-1,4,7,14,17-pentazabicyclo[16.3.1]docosan-12-yl]-5-(carbamoylamino)-2-(2-methylpropanoylamino)pentanamide
اینچی
-
InChI=1S/C50H73N9O12/c1-9-29(6)40-49(69)71-30(7)41(57-43(63)34(53-42(62)28(4)5)16-13-23-52-50(51)70)46(66)55-36(24-27(2)3)44(64)54-35-21-22-39(61)59(47(35)67)38(26-31-14-11-10-12-15-31)48(68)58(8)37(45(65)56-40)25-32-17-19-33(60)20-18-32/h10-12,14-15,17-20,27-30,34-41,60-61H,9,13,16,21-26H2,1-8H3,(H,53,62)(H,54,64)(H,55,66)(H,56,65)(H,57,63)(H3,51,52,70)/t29-,30-,34+,35+,36+,37?,38+,39-,40+,41+/m1/s1
اینچیکی
-
MTEWLNRVQLKTFS-DHWKTPHLSA-N
اسمایلٓ
-
O[C@H]1N2[C@@H](CC3=CC=CC=C3)C(=O)N(C(CC4=CC=C(O)C=C4)C(=O)N[C@@]([C@@H](CC)C)(C(O[C@@H]([C@H](NC(=O)[C@@H](NC(=O)C(C)C)CCCNC(=O)N)C(=O)N[C@H](C(=O)N[C@@](CC1)(C2=O)[H])CC(C)C)C)=O)[H])C
مترادف دقیق
-
(2S)-N-[(2S,8S,11R,12S,15S,18S,21R)-2-benzyl-8-[(2R)-butan-2-yl]-21-hydroxy-5-[(4-hydroxyphenyl)methyl]-4,11-dimethyl-15-(2-methylpropyl)-3,6,9,13,16,22-hexaoxo-10-oxa-1,4,7,14,17-pentazabicyclo[16.3.1]docosan-12-yl]-5-(carbamoylamino)-2-(2-methylpropanoylamino)pentanamide
-
(2S) N [(2S,8S,11R,12S,15S,18S,21R) 2 Benzyl 8 [(2R) butan 2 yl] 21 hydroxy 5 [(4 hydroxyphenyl)methyl] 4,11 dimethyl 15 (2 methylpropyl , 3,1,6,6,9,1,1,6,9 1،4،7،14،17 pentazabicyclo[16.3.1]docosan 12 yl] 5 (carbamoylamino) 2 (2 methylpropanoylamino)pentanamide
URI
http://www.irandoc.acir/onto/irandoc/CHEBI:182924